We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Fair Isaac
FICO
$28.7B
| $1.99M | 0.01% |
5,315
+2,677
| +101% | +$901K |
|
777
SS&C Technologies
SSNC
$17.8B
| $1.99M | 0.01% |
32,428
-30,618
| -49% | -$1.72M |
|
|
RAVN
778
DELISTED
Raven Industries Inc
RAVN
| $1.99M | 0.01% |
57,605
| – | – |
|
779
Sun Communities
SUI
$15B
| $1.98M | 0.01% |
13,210
-1,375
| -9% | -$214K |
|
780
DNP Select Income Fund
DNP
$4.18B
| $1.97M | 0.01% |
154,085
+5,465
| +4% | +$69.6K |
|
781
Enviri
NVRI
$621M
| $1.97M | 0.01% |
85,535
+12,537
| +17% | +$262K |
|
782
Campbell Soup
CPB
$6.51B
| $1.97M | 0.01% |
39,759
-688
| -2% | -$32.6K |
|
|
DSKE
783
DELISTED
Daseke, Inc. Common Stock
DSKE
| $1.96M | 0.01% |
618,974
| – | – |
|
784
Canadian Pacific Kansas City
CP
$82B
| $1.95M | 0.01% |
38,235
-4,695
| -11% | -$220K |
|
785
Lloyds Banking Group
LYG
$87.4B
| $1.95M | 0.01% |
589,048
-120,473
| -17% | -$364K |
|
|
SEE
786
DELISTED
Sealed Air
SEE
| $1.95M | 0.01% |
48,948
-2,077
| -4% | -$82.3K |
|
787
Hexcel
HXL
$8.32B
| $1.93M | ﹤0.01% |
26,386
-584
| -2% | -$44.9K |
|
788
Emcor
EME
$33.1B
| $1.93M | ﹤0.01% |
22,389
-1,470
| -6% | -$129K |
|
|
ALE
789
DELISTED
Allete
ALE
| $1.93M | ﹤0.01% |
23,751
+153
| +0.6% | +$12.7K |
|
790
Etsy
ETSY
$7.65B
| $1.93M | ﹤0.01% |
43,534
-8,289
| -16% | -$395K |
|
791
GATX Corp
GATX
$6.55B
| $1.92M | ﹤0.01% |
23,223
+293
| +1% | +$23.6K |
|
792
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$690M
| $1.92M | ﹤0.01% |
44,905
-2,265
| -5% | -$94.8K |
|
793
RELX
RELX
$60.1B
| $1.91M | ﹤0.01% |
75,696
-3,642
| -5% | -$87.1K |
|
794
British American Tobacco
BTI
$132B
| $1.91M | ﹤0.01% |
44,931
-1,881
| -4% | -$70.9K |
|
795
Workday
WDAY
$33.4B
| $1.91M | ﹤0.01% |
11,583
-961
| -8% | -$160K |
|
796
Teradyne
TER
$54.8B
| $1.9M | ﹤0.01% |
27,913
+1,931
| +7% | +$123K |
|
797
DXC Technology
DXC
$1.63B
| $1.9M | ﹤0.01% |
50,517
+7,766
| +18% | +$253K |
|
798
Vanguard Large-Cap ETF
VV
$51.9B
| $1.9M | ﹤0.01% |
12,830
+1,037
| +9% | +$147K |
|
799
Arch Capital
ACGL
$36.1B
| $1.9M | ﹤0.01% |
44,249
+3,490
| +9% | +$145K |
|
|
MANT
800
DELISTED
Mantech International Corp
MANT
| $1.9M | ﹤0.01% |
23,730
-349
| -1% | -$26.2K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.